BRICKELL BIOTECH INC (BBI) Stock Analyst Ratings
USA - NASDAQ:BBI - US10802T2042 - Common Stock
2.35 USD
+0.05 (+2.17%)
ChartMill assigns a Buy % Consensus number of 83% to BBI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.19. This target is 674.04% above the current price.
BBI was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BBI.
In the previous month the buy percentage consensus was at a similar level.
BBI was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-13 | Lake Street | Downgrade | Buy -> Hold |
| 2022-03-08 | William Blair | Initiate | Outperform |
| 2022-01-18 | HC Wainwright & Co. | Initiate | Buy |
BRICKELL BIOTECH INC / BBI FAQ
What do analysts expect the price target to be for BRICKELL BIOTECH INC (BBI)?
8 analysts have analysed BBI and the average price target is 18.19 USD. This implies a price increase of 674.04% is expected in the next year compared to the current price of 2.35.
What is the consensus rating for BRICKELL BIOTECH INC (BBI) stock?
The consensus rating for BRICKELL BIOTECH INC (BBI) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.